J07BX05
respiratory syncytial virus vaccines
Наименование на групата: WHO Collaborating Centre for Drug Statistics Methodology
Лекарствени продукти в тази категория
3 продукта в тази категория и подгрупите ѝ.
| Търговско име | Концентрация |
|---|---|
| Abrysvo | --¹ After reconstitution, one dose (0.5 mL) contains: RSV subgroup A stabilised prefusion F antigen*,** 60 micrograms RSV subgroup B stabilised prefusion F antigen*,** 60 micrograms * glycoprotein F stabilised in the prefusion conformation ** produced in Chinese Hamster Ovary cells by recombinant DNA technology |
| AREXVY | --¹ After reconstitution, one dose (0.5 mL) contains: RSVPreF3¹ antigen²,³ 120 micrograms ¹ Respiratory Syncytial Virus recombinant glycoprotein F stabilised in the pre-fusion conformation = RSVPreF3 ² RSVPreF3 produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology ³ adjuvanted with AS01E containing: plant extract Quillaja saponaria Molina, fraction 21 (QS-21) 25 micrograms 3-O-desacyl-4’-monophosphoryl lipid A (MPL) from Salmonella minnesota 25 micrograms |
| mRESVIA | --¹ One dose (0.5 mL) contains 50 micrograms of RSV mRNA (nucleoside modified) encapsulated in lipid nanoparticles. |